Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 17/20 | 0.48 |
| ▸ | GGPS1 | O95749 | 8/20 | 0.43 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.42 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5494372 | 0.79 | LMNA (0.39) | FDPSGGPS1PDE3ALMNAADRB3 | |
| SCHEMBL23038652 | 0.77 | LMNA (0.43) | FDPSGGPS1PDE3ALMNAADRB3 | |
| Iodide SCHEMBL8467505 | 0.75 | FDPS (0.56) | FDPSGGPS1PDE3ALMNAADRB3 | |
| SCHEMBL2553124 | 0.75 | PGK1 (0.39) | FDPSGGPS1LMNABBOX1 | |
| SCHEMBL15778355 | 0.75 | LMNA (0.36) | FDPSGGPS1PDE3ALMNAADRB3 | |
| SCHEMBL737339 | 0.75 | FDPS (0.40) | FDPSGGPS1PDE3ALMNAADRB3 | |
| SCHEMBL192295 | 0.73 | FDPS (0.38) | FDPSGGPS1LMNABBOX1 | |
| Hydrochloric Acid SCHEMBL9546790 | 0.73 | FDPS (0.54) | FDPSGGPS1PDE3ALMNAADRB3 | |
| SCHEMBL23001089 | 0.72 | FDPS (0.45) | FDPSGGPS1BBOX1 | |
| SCHEMBL1692406 | 0.72 | FDPS (0.52) | FDPSGGPS1PDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240325324-A1 | COMPOSITIONS AND METHODS FOR TREATING DRY EYE | Genetic Disease Investigators, LLC | 2024-10-03 | — | — | US | claimed |
| WO-2022271362-A1 | COMPOSITION AND METHODS FOR TREATING DRY EYE | DRISCOLL DIANA (US) | 2022-12-29 | — | — | WO | claimed |
| US-20220409639-A1 | COMPOSITIONS AND METHODS FOR TREATING DRY EYE | Genetic Disease Investigators, LLC | 2022-12-29 | — | — | US | claimed |
| WO-2012164525-A2 | AGING BIOMARKERS | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2012-12-06 | — | — | WO | claimed |
| EP-2411028-A1 | Therapy for promoting cell growth | Moleac Pte Ltd. (SG) | 2012-02-01 | — | — | EP | claimed |
| WO-2010110755-A1 | THERAPY FOR PROMOTING CELL GROWTH | MOLEAC PTE. LTD. (SG) | 2010-09-30 | — | — | WO | claimed |
| EP-0408668-A4 | PROCESS FOR INCREASING PHOSPHATIDYLCHOLINE IN VIVO | — | 1991-11-27 | — | — | EP | claimed |
| EP-0435886-A1 | ENHANCEMENT OF RELEASE OF NEUROTRANSMITTERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1991-07-10 | — | — | EP | claimed |
| EP-0408668-A1 | PROCESS FOR INCREASING PHOSPHATIDYLCHOLINE IN VIVO. | MASSACHUSETTS INST TECHNOLOGY (US) | 1991-01-23 | — | — | EP | claimed |
| WO-1990004400-A1 | PROCESS FOR INCREASING PHOSPHATIDYLCHOLINE $i(IN VIVO) | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1990-05-03 | — | — | WO | claimed |
| WO-1990002554-A1 | ENHANCEMENT OF RELEASE OF NEUROTRANSMITTERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1990-03-22 | — | — | WO | claimed |
| EP-0125900-B1 | A PHARMACEUTICAL COMPOSITION FOR USE IN TREATING NEUROLOGICAL DISEASE OR AGING | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1989-08-23 | — | — | EP | claimed |
| US-4609647-A | Cytidyl diphosphocholine-drug composition and process | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1986-09-02 | — | — | US | claimed |
| US-4569929-A | Cytidyl diphosphocholine-drug composition | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1986-02-11 | — | — | US | claimed |
| EP-0147185-A2 | Therapeutic use of cytidyl disphosphocholine to increase neuronal acetylcholine | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1985-07-03 | — | — | EP | claimed |
| EP-4213828-B1 | PHARMACEUTICAL COMPOSITION COMPRISING URIDINE AND PYRUVATE FOR REGULATING THE PROLIFERATION, ACTIVITY AND SURVIVAL OF IMMUNE CELLS | GV SQUARED S R L (IT) | 2025-08-27 | — | — | EP | disclosed |
| US-20250250647-A1 | STABLE CELL CLONES HARBORING REPLICATING SARS-COV-2 RNA | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN (US) | 2025-08-07 | — | — | US | disclosed |
| EP-0001197-B1 | COUPLING PRODUCTS OF CYTIDINE-DIPHOSPHOCHOLINE AND AMINO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL AND ANALYTICAL APPLICATION | Etablissement public dit: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 1981-11-04 | — | — | EP | disclosed |
| EP-0001197-A2 | Coupling products of cytidine-diphosphocholine and amino compounds, process for their preparation and their pharmaceutical and analytical application | Etablissement public dit: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 1979-03-21 | — | — | EP | disclosed |
| EP-0001197-A2 | Coupling products of cytidine-diphosphocholine and amino compounds, process for their preparation and their pharmaceutical and analytical application | Etablissement public dit: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 1979-03-21 | — | — | EP | disclosed |